Risk factor
Very high price volatility
Profitability factor
Favourable analyst view
About
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.
Target Price
The average target price of ABSI is 8.4 and suggests 38% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas